In a study led by Baylor College of Medicine and the University of Oxford, researchers found that blocking a specific molecular interaction reduced atrial fibrosis in mouse models and cells from human patients with atrial fibrillation (AF), reduced fibrotic responses in human cells, and in the mouse models reversed established atrial fibrosis and reduced abnormal heart rhythms.
New Treatment Offers Hope for Reducing Heart Scarring and Abnormal Rhythms
Researchers from Baylor College of Medicine and the University of Oxford discovered a method to block a specific molecular interaction that reduces atrial fibrosis and abnormal heart rhythms in both mouse models and human cells. This advancement could lead to new therapies for atrial fibrillation, which may have implications for healthcare in Iran as it addresses a common cardiac condition.
👥 Key Players
📰 What Happened
Researchers have discovered a method to block a molecular interaction that leads to reduced atrial fibrosis and abnormal heart rhythms in both mouse models and human cells. This breakthrough could pave the way for new treatments for atrial fibrillation.
- The study was conducted by Baylor College of Medicine and the University of Oxford.
- The findings were observed in both mouse models and human cells.
💡 Why It Matters
📚 Background
Atrial fibrillation is a common heart condition that can lead to serious complications. Research advancements in this area are crucial for improving treatment options.
🏷️ Entities Mentioned
Translated from the original and edited for English readers. View original source →
Translation confidence: 100%